Investigator Initiated Studies

Relypsa supports independent investigators in conducting Investigator Initiated Studies (IIS) that are focused on hyperkalemia and associated conditions. Through such efforts, Relypsa’s aim is to obtain valuable clinical and scientific information and ultimately to improve patient care.

Request Process and Requirements

All organizations seeking IIS funding from Relypsa should first submit an IIS application form to iis@relypsa.com. To obtain the application form, please contact your local field-based Medical Science Director or email us at iis@relypsa.com.

Evaluation of Requests

The IIS Review Committee (“IISRC”) evaluates all IIS proposals and Investigators based on several criteria, including Relypsa’s corporate policies and objectives, and compliance with any applicable U.S. Food and Drug Administration or federal healthcare program requirements. The use, purchase or prescription of Relypsa products or the recipient’s potential to influence the use, purchase or prescription of those products will not be considered when deciding on a research concept.

Contact Information

For further information on requesting IIS funding from Relypsa, please contact your local field-based Medical Science Director or email us at iis@relypsa.com.